Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Moelis & Company (MC.N)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2021-08-1362.2562.00Buy
2021-10-0164.8370.00Buy
2021-10-2768.5674.00Buy
2021-11-0476.1285.00Buy
2022-01-0462.6573.00Buy
2022-02-0958.4769.00Buy
2022-03-3146.9560.00Buy
2022-04-2744.8854.00Buy
2022-07-0639.9940.00Neutral
2022-07-2743.9343.00Neutral
2022-09-2237.0435.00Sell
2022-11-0243.0132.00Sell
2023-01-0942.8430.00Sell
2023-04-1140.2327.00Sell
2023-07-1045.8732.00Sell
2023-07-3148.8329.00Sell
2023-10-0343.6530.00Sell
2023-11-0343.3632.00Sell
2024-02-1256.0846.00Sell
2024-03-2555.3345.00Sell
2024-04-2550.2647.00Sell
2024-07-0857.7850.00Sell
2024-07-2566.8254.00Sell
2024-10-0766.6060.00Sell
2024-10-2765.8962.00Sell

Disclosures

  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.